Relevance	O
of	O
ID3	B:C1415856
-	O
TCF3	O
-	O
CCND3	O
pathway	O
mutations	I:C0026882
in	O
pediatric	O
aggressive	O
B	I:C0079731
-	I:C0079731
cell	I:C0079731
lymphoma	I:C0079731
treated	O
according	O
to	O
the	O
NHL	O
-	I:C0040808
BFM	I:C0040808
protocols	I:C0040808
Mature	O
B-	I:C1334634
cell	I:C1334634
Non-Hodgkin	I:C1334634
lymphoma	I:C1334634
is	O
the	O
most	O
common	O
subtype	O
of	O
Non-Hodgkin	O
lymphoma	I:C0220612
in	I:C0220612
childhood	I:C0220612
and	O
adolescence	O
.	O

Relevance	O
of	O
ID3	O
-	O
TCF3	B:C1336596
-	O
CCND3	O
pathway	O
mutations	I:C0026882
in	O
pediatric	O
aggressive	O
B	I:C0079731
-	I:C0079731
cell	I:C0079731
lymphoma	I:C0079731
treated	O
according	O
to	O
the	O
NHL	O
-	I:C0040808
BFM	I:C0040808
protocols	I:C0040808
Mature	O
B-	I:C1334634
cell	I:C1334634
Non-Hodgkin	I:C1334634
lymphoma	I:C1334634
is	O
the	O
most	O
common	O
subtype	O
of	O
Non-Hodgkin	O
lymphoma	I:C0220612
in	I:C0220612
childhood	I:C0220612
and	O
adolescence	O
.	O

Relevance	O
of	O
ID3	O
-	O
TCF3	O
-	O
CCND3	B:C1413175
pathway	O
mutations	I:C0026882
in	O
pediatric	O
aggressive	O
B	I:C0079731
-	I:C0079731
cell	I:C0079731
lymphoma	I:C0079731
treated	O
according	O
to	O
the	O
NHL	O
-	I:C0040808
BFM	I:C0040808
protocols	I:C0040808
Mature	O
B-	I:C1334634
cell	I:C1334634
Non-Hodgkin	I:C1334634
lymphoma	I:C1334634
is	O
the	O
most	O
common	O
subtype	O
of	O
Non-Hodgkin	O
lymphoma	I:C0220612
in	I:C0220612
childhood	I:C0220612
and	O
adolescence	O
.	O

Relevance	O
of	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	B:C0026882
mutations	I:C0026882
in	O
pediatric	O
aggressive	O
B	I:C0079731
-	I:C0079731
cell	I:C0079731
lymphoma	I:C0079731
treated	O
according	O
to	O
the	O
NHL	O
-	I:C0040808
BFM	I:C0040808
protocols	I:C0040808
Mature	O
B-	I:C1334634
cell	I:C1334634
Non-Hodgkin	I:C1334634
lymphoma	I:C1334634
is	O
the	O
most	O
common	O
subtype	O
of	O
Non-Hodgkin	O
lymphoma	I:C0220612
in	I:C0220612
childhood	I:C0220612
and	O
adolescence	O
.	O

Relevance	O
of	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	O
mutations	I:C0026882
in	O
pediatric	O
aggressive	B:C0079731
B	I:C0079731
-	I:C0079731
cell	I:C0079731
lymphoma	I:C0079731
treated	O
according	O
to	O
the	O
NHL	O
-	I:C0040808
BFM	I:C0040808
protocols	I:C0040808
Mature	O
B-	I:C1334634
cell	I:C1334634
Non-Hodgkin	I:C1334634
lymphoma	I:C1334634
is	O
the	O
most	O
common	O
subtype	O
of	O
Non-Hodgkin	O
lymphoma	I:C0220612
in	I:C0220612
childhood	I:C0220612
and	O
adolescence	O
.	O

Relevance	O
of	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	O
mutations	I:C0026882
in	O
pediatric	O
aggressive	O
B	I:C0079731
-	I:C0079731
cell	I:C0079731
lymphoma	I:C0079731
treated	O
according	O
to	O
the	O
NHL	B:C0040808
-	I:C0040808
BFM	I:C0040808
protocols	I:C0040808
Mature	O
B-	I:C1334634
cell	I:C1334634
Non-Hodgkin	I:C1334634
lymphoma	I:C1334634
is	O
the	O
most	O
common	O
subtype	O
of	O
Non-Hodgkin	O
lymphoma	I:C0220612
in	I:C0220612
childhood	I:C0220612
and	O
adolescence	O
.	O

Relevance	O
of	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	O
mutations	I:C0026882
in	O
pediatric	O
aggressive	O
B	I:C0079731
-	I:C0079731
cell	I:C0079731
lymphoma	I:C0079731
treated	O
according	O
to	O
the	O
NHL	O
-	I:C0040808
BFM	I:C0040808
protocols	I:C0040808
Mature	B:C1334634
B-	I:C1334634
cell	I:C1334634
Non-Hodgkin	I:C1334634
lymphoma	I:C1334634
is	O
the	O
most	O
common	O
subtype	O
of	O
Non-Hodgkin	O
lymphoma	I:C0220612
in	I:C0220612
childhood	I:C0220612
and	O
adolescence	O
.	O

Relevance	O
of	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	O
mutations	I:C0026882
in	O
pediatric	O
aggressive	O
B	I:C0079731
-	I:C0079731
cell	I:C0079731
lymphoma	I:C0079731
treated	O
according	O
to	O
the	O
NHL	O
-	I:C0040808
BFM	I:C0040808
protocols	I:C0040808
Mature	O
B-	I:C1334634
cell	I:C1334634
Non-Hodgkin	I:C1334634
lymphoma	I:C1334634
is	O
the	O
most	O
common	O
subtype	B:C0449560
of	O
Non-Hodgkin	O
lymphoma	I:C0220612
in	I:C0220612
childhood	I:C0220612
and	O
adolescence	O
.	O

Relevance	O
of	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	O
mutations	I:C0026882
in	O
pediatric	O
aggressive	O
B	I:C0079731
-	I:C0079731
cell	I:C0079731
lymphoma	I:C0079731
treated	O
according	O
to	O
the	O
NHL	O
-	I:C0040808
BFM	I:C0040808
protocols	I:C0040808
Mature	O
B-	I:C1334634
cell	I:C1334634
Non-Hodgkin	I:C1334634
lymphoma	I:C1334634
is	O
the	O
most	O
common	O
subtype	O
of	O
Non-Hodgkin	B:C0220612
lymphoma	I:C0220612
in	I:C0220612
childhood	I:C0220612
and	O
adolescence	O
.	O

B	B:C0079731
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
are	O
further	O
classified	O
into	O
histological	O
subtypes	I:C0449560
,	O
with	O
Burkitt	O
lymphoma	I:C0006413
and	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
being	O
the	O
most	O
common	O
subgroups	O
in	O
pediatric	O
patients	O
.	O

B	O
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
are	O
further	O
classified	O
into	O
histological	B:C0449560
subtypes	I:C0449560
,	O
with	O
Burkitt	O
lymphoma	I:C0006413
and	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
being	O
the	O
most	O
common	O
subgroups	O
in	O
pediatric	O
patients	O
.	O

B	O
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
are	O
further	O
classified	O
into	O
histological	O
subtypes	I:C0449560
,	O
with	O
Burkitt	B:C0006413
lymphoma	I:C0006413
and	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
being	O
the	O
most	O
common	O
subgroups	O
in	O
pediatric	O
patients	O
.	O

B	O
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
are	O
further	O
classified	O
into	O
histological	O
subtypes	I:C0449560
,	O
with	O
Burkitt	O
lymphoma	I:C0006413
and	O
Diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
being	O
the	O
most	O
common	O
subgroups	O
in	O
pediatric	O
patients	O
.	O

B	O
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
are	O
further	O
classified	O
into	O
histological	O
subtypes	I:C0449560
,	O
with	O
Burkitt	O
lymphoma	I:C0006413
and	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
being	O
the	O
most	O
common	O
subgroups	B:C1515021
in	O
pediatric	O
patients	O
.	O

Translocations	B:C1315049
involving	O
the	O
MYC	O
oncogene	I:C0086661
are	O
known	O
as	O
relevant	O
but	O
not	O
sufficient	O
hit	O
for	O
Burkitt	O
lymphoma	I:C0006413
pathogenesis	O
.	O

Translocations	O
involving	O
the	O
MYC	B:C0086661
oncogene	I:C0086661
are	O
known	O
as	O
relevant	O
but	O
not	O
sufficient	O
hit	O
for	O
Burkitt	O
lymphoma	I:C0006413
pathogenesis	O
.	O

Translocations	O
involving	O
the	O
MYC	O
oncogene	I:C0086661
are	O
known	O
as	O
relevant	O
but	O
not	O
sufficient	O
hit	O
for	O
Burkitt	B:C0006413
lymphoma	I:C0006413
pathogenesis	O
.	O

Translocations	O
involving	O
the	O
MYC	O
oncogene	I:C0086661
are	O
known	O
as	O
relevant	O
but	O
not	O
sufficient	O
hit	O
for	O
Burkitt	O
lymphoma	I:C0006413
pathogenesis	B:C0699748
.	O

Recently	O
published	O
large	B:C1294197
-	I:C1294197
scale	I:C1294197
next	I:C1294197
-	I:C1294197
generation	I:C1294197
sequencing	I:C1294197
studies	I:C1294197
unveiled	O
sets	O
of	O
additional	O
recurrently	O
mutated	O
genes	I:C0017337
in	O
samples	O
of	O
pediatric	O
and	O
adult	O
B	O
-	O
cell	O
Non-Hodgkin	O
lymphoma	O
patients	O
.	O

Recently	O
published	O
large	O
-	I:C1294197
scale	I:C1294197
next	I:C1294197
-	I:C1294197
generation	I:C1294197
sequencing	I:C1294197
studies	I:C1294197
unveiled	O
sets	O
of	O
additional	O
recurrently	O
mutated	B:C0017337
genes	I:C0017337
in	O
samples	O
of	O
pediatric	O
and	O
adult	O
B	O
-	O
cell	O
Non-Hodgkin	O
lymphoma	O
patients	O
.	O

ID3	B:C1415856
,	O
TCF3	O
and	O
CCND3	O
are	O
potential	O
drivers	O
of	O
Burkitt	O
-	I:C0598766
lymphomagenesis	I:C0598766
.	O

ID3	O
,	O
TCF3	B:C1336596
and	O
CCND3	O
are	O
potential	O
drivers	O
of	O
Burkitt	O
-	I:C0598766
lymphomagenesis	I:C0598766
.	O

ID3	O
,	O
TCF3	O
and	O
CCND3	B:C1413175
are	O
potential	O
drivers	O
of	O
Burkitt	O
-	I:C0598766
lymphomagenesis	I:C0598766
.	O

ID3	O
,	O
TCF3	O
and	O
CCND3	O
are	O
potential	O
drivers	O
of	O
Burkitt	B:C0598766
-	I:C0598766
lymphomagenesis	I:C0598766
.	O

In	O
the	O
present	O
study	O
frequency	O
and	O
clinical	O
relevance	O
of	O
mutations	B:C0026882
in	O
ID3	O
,	O
TCF3	O
and	O
CCND3	O
were	O
analyzed	O
within	O
a	O
well	O
-	O
defined	O
cohort	O
of	O
84	O
uniformly	O
diagnosed	O
and	O
treated	O
pediatric	O
B	O
-	O
cell	O
Non-Hodgkin	O
lymphoma	O
patients	O
of	O
the	O
Berlin	O
-	I:C0008902
Frankfurt	I:C0008902
-	I:C0008902
Munster	I:C0008902
group	I:C0008902
(	O
NHL	O
-	I:C0008902
BFM	I:C0008902
)	O
.	O

In	O
the	O
present	O
study	O
frequency	O
and	O
clinical	O
relevance	O
of	O
mutations	O
in	O
ID3	B:C1415856
,	O
TCF3	O
and	O
CCND3	O
were	O
analyzed	O
within	O
a	O
well	O
-	O
defined	O
cohort	O
of	O
84	O
uniformly	O
diagnosed	O
and	O
treated	O
pediatric	O
B	O
-	O
cell	O
Non-Hodgkin	O
lymphoma	O
patients	O
of	O
the	O
Berlin	O
-	I:C0008902
Frankfurt	I:C0008902
-	I:C0008902
Munster	I:C0008902
group	I:C0008902
(	O
NHL	O
-	I:C0008902
BFM	I:C0008902
)	O
.	O

In	O
the	O
present	O
study	O
frequency	O
and	O
clinical	O
relevance	O
of	O
mutations	O
in	O
ID3	O
,	O
TCF3	B:C1336596
and	O
CCND3	O
were	O
analyzed	O
within	O
a	O
well	O
-	O
defined	O
cohort	O
of	O
84	O
uniformly	O
diagnosed	O
and	O
treated	O
pediatric	O
B	O
-	O
cell	O
Non-Hodgkin	O
lymphoma	O
patients	O
of	O
the	O
Berlin	O
-	I:C0008902
Frankfurt	I:C0008902
-	I:C0008902
Munster	I:C0008902
group	I:C0008902
(	O
NHL	O
-	I:C0008902
BFM	I:C0008902
)	O
.	O

In	O
the	O
present	O
study	O
frequency	O
and	O
clinical	O
relevance	O
of	O
mutations	O
in	O
ID3	O
,	O
TCF3	O
and	O
CCND3	B:C1413175
were	O
analyzed	O
within	O
a	O
well	O
-	O
defined	O
cohort	O
of	O
84	O
uniformly	O
diagnosed	O
and	O
treated	O
pediatric	O
B	O
-	O
cell	O
Non-Hodgkin	O
lymphoma	O
patients	O
of	O
the	O
Berlin	O
-	I:C0008902
Frankfurt	I:C0008902
-	I:C0008902
Munster	I:C0008902
group	I:C0008902
(	O
NHL	O
-	I:C0008902
BFM	I:C0008902
)	O
.	O

In	O
the	O
present	O
study	O
frequency	O
and	O
clinical	O
relevance	O
of	O
mutations	O
in	O
ID3	O
,	O
TCF3	O
and	O
CCND3	O
were	O
analyzed	O
within	O
a	O
well	O
-	O
defined	O
cohort	B:C0599755
of	O
84	O
uniformly	O
diagnosed	O
and	O
treated	O
pediatric	O
B	O
-	O
cell	O
Non-Hodgkin	O
lymphoma	O
patients	O
of	O
the	O
Berlin	O
-	I:C0008902
Frankfurt	I:C0008902
-	I:C0008902
Munster	I:C0008902
group	I:C0008902
(	O
NHL	O
-	I:C0008902
BFM	I:C0008902
)	O
.	O

In	O
the	O
present	O
study	O
frequency	O
and	O
clinical	O
relevance	O
of	O
mutations	O
in	O
ID3	O
,	O
TCF3	O
and	O
CCND3	O
were	O
analyzed	O
within	O
a	O
well	O
-	O
defined	O
cohort	O
of	O
84	O
uniformly	O
diagnosed	O
and	O
treated	O
pediatric	O
B	O
-	O
cell	O
Non-Hodgkin	O
lymphoma	O
patients	O
of	O
the	O
Berlin	B:C0008902
-	I:C0008902
Frankfurt	I:C0008902
-	I:C0008902
Munster	I:C0008902
group	I:C0008902
(	O
NHL	O
-	I:C0008902
BFM	I:C0008902
)	O
.	O

In	O
the	O
present	O
study	O
frequency	O
and	O
clinical	O
relevance	O
of	O
mutations	O
in	O
ID3	O
,	O
TCF3	O
and	O
CCND3	O
were	O
analyzed	O
within	O
a	O
well	O
-	O
defined	O
cohort	O
of	O
84	O
uniformly	O
diagnosed	O
and	O
treated	O
pediatric	O
B	O
-	O
cell	O
Non-Hodgkin	O
lymphoma	O
patients	O
of	O
the	O
Berlin	O
-	I:C0008902
Frankfurt	I:C0008902
-	I:C0008902
Munster	I:C0008902
group	I:C0008902
(	O
NHL	B:C0008902
-	I:C0008902
BFM	I:C0008902
)	O
.	O

Mutation	O
frequency	O
was	O
78	O
%	O
(	O
ID3	B:C1415856
)	O
,	O
13	O
%	O
(	O
TCF3	O
)	O
and	O
36	O
%	O
(	O
CCND3	O
)	O
in	O
Burkitt	O
lymphoma	I:C0006413
(	O
including	O
Burkitt	O
leukemia	I:C0006413
)	O
.	O

Mutation	O
frequency	O
was	O
78	O
%	O
(	O
ID3	O
)	O
,	O
13	O
%	O
(	O
TCF3	B:C1336596
)	O
and	O
36	O
%	O
(	O
CCND3	O
)	O
in	O
Burkitt	O
lymphoma	I:C0006413
(	O
including	O
Burkitt	O
leukemia	I:C0006413
)	O
.	O

Mutation	O
frequency	O
was	O
78	O
%	O
(	O
ID3	O
)	O
,	O
13	O
%	O
(	O
TCF3	O
)	O
and	O
36	O
%	O
(	O
CCND3	B:C1413175
)	O
in	O
Burkitt	O
lymphoma	I:C0006413
(	O
including	O
Burkitt	O
leukemia	I:C0006413
)	O
.	O

Mutation	O
frequency	O
was	O
78	O
%	O
(	O
ID3	O
)	O
,	O
13	O
%	O
(	O
TCF3	O
)	O
and	O
36	O
%	O
(	O
CCND3	O
)	O
in	O
Burkitt	B:C0006413
lymphoma	I:C0006413
(	O
including	O
Burkitt	O
leukemia	I:C0006413
)	O
.	O

Mutation	O
frequency	O
was	O
78	O
%	O
(	O
ID3	O
)	O
,	O
13	O
%	O
(	O
TCF3	O
)	O
and	O
36	O
%	O
(	O
CCND3	O
)	O
in	O
Burkitt	O
lymphoma	I:C0006413
(	O
including	O
Burkitt	B:C0006413
leukemia	I:C0006413
)	O
.	O

ID3	B:C1415856
and	O
CCND3	O
mutations	O
were	O
associated	O
with	O
more	O
advanced	O
stages	O
of	O
the	O
disease	O
in	O
MYC	O
rearrangement	O
positive	I:C0006413
Burkitt	I:C0006413
lymphoma	I:C0006413
.	O

ID3	O
and	O
CCND3	B:C1413175
mutations	O
were	O
associated	O
with	O
more	O
advanced	O
stages	O
of	O
the	O
disease	O
in	O
MYC	O
rearrangement	O
positive	I:C0006413
Burkitt	I:C0006413
lymphoma	I:C0006413
.	O

ID3	O
and	O
CCND3	O
mutations	B:C0026882
were	O
associated	O
with	O
more	O
advanced	O
stages	O
of	O
the	O
disease	O
in	O
MYC	O
rearrangement	O
positive	I:C0006413
Burkitt	I:C0006413
lymphoma	I:C0006413
.	O

ID3	O
and	O
CCND3	O
mutations	O
were	O
associated	O
with	O
more	O
advanced	O
stages	O
of	O
the	O
disease	O
in	O
MYC	B:C0086661
rearrangement	O
positive	I:C0006413
Burkitt	I:C0006413
lymphoma	I:C0006413
.	O

ID3	O
and	O
CCND3	O
mutations	O
were	O
associated	O
with	O
more	O
advanced	O
stages	O
of	O
the	O
disease	O
in	O
MYC	O
rearrangement	B:C0006413
positive	I:C0006413
Burkitt	I:C0006413
lymphoma	I:C0006413
.	O

In	O
conclusion	O
ID3	B:C1415856
-	O
TCF3	O
-	O
CCND3	O
pathway	O
genes	O
are	O
mutated	O
in	O
more	O
than	O
88	O
%	O
of	O
MYC	O
-	O
rearranged	O
pediatric	I:C0079731
B	I:C0079731
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
and	O
the	O
pathway	O
may	O
represent	O
a	O
highly	O
relevant	O
second	O
hit	O
of	O
Burkitt	O
lymphoma	I:C0006413
pathogenesis	O
especially	O
in	O
children	O
and	O
adolescents	O
.	O

In	O
conclusion	O
ID3	O
-	O
TCF3	B:C1336596
-	O
CCND3	O
pathway	O
genes	O
are	O
mutated	O
in	O
more	O
than	O
88	O
%	O
of	O
MYC	O
-	O
rearranged	O
pediatric	I:C0079731
B	I:C0079731
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
and	O
the	O
pathway	O
may	O
represent	O
a	O
highly	O
relevant	O
second	O
hit	O
of	O
Burkitt	O
lymphoma	I:C0006413
pathogenesis	O
especially	O
in	O
children	O
and	O
adolescents	O
.	O

In	O
conclusion	O
ID3	O
-	O
TCF3	O
-	O
CCND3	B:C1413175
pathway	O
genes	O
are	O
mutated	O
in	O
more	O
than	O
88	O
%	O
of	O
MYC	O
-	O
rearranged	O
pediatric	I:C0079731
B	I:C0079731
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
and	O
the	O
pathway	O
may	O
represent	O
a	O
highly	O
relevant	O
second	O
hit	O
of	O
Burkitt	O
lymphoma	I:C0006413
pathogenesis	O
especially	O
in	O
children	O
and	O
adolescents	O
.	O

In	O
conclusion	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	O
genes	B:C0017337
are	O
mutated	O
in	O
more	O
than	O
88	O
%	O
of	O
MYC	O
-	O
rearranged	O
pediatric	I:C0079731
B	I:C0079731
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
and	O
the	O
pathway	O
may	O
represent	O
a	O
highly	O
relevant	O
second	O
hit	O
of	O
Burkitt	O
lymphoma	I:C0006413
pathogenesis	O
especially	O
in	O
children	O
and	O
adolescents	O
.	O

In	O
conclusion	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	O
genes	O
are	O
mutated	O
in	O
more	O
than	O
88	O
%	O
of	O
MYC	B:C0086661
-	O
rearranged	O
pediatric	I:C0079731
B	I:C0079731
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
and	O
the	O
pathway	O
may	O
represent	O
a	O
highly	O
relevant	O
second	O
hit	O
of	O
Burkitt	O
lymphoma	I:C0006413
pathogenesis	O
especially	O
in	O
children	O
and	O
adolescents	O
.	O

In	O
conclusion	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	O
genes	O
are	O
mutated	O
in	O
more	O
than	O
88	O
%	O
of	O
MYC	O
-	O
rearranged	B:C0079731
pediatric	I:C0079731
B	I:C0079731
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
and	O
the	O
pathway	O
may	O
represent	O
a	O
highly	O
relevant	O
second	O
hit	O
of	O
Burkitt	O
lymphoma	I:C0006413
pathogenesis	O
especially	O
in	O
children	O
and	O
adolescents	O
.	O

In	O
conclusion	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	O
genes	O
are	O
mutated	O
in	O
more	O
than	O
88	O
%	O
of	O
MYC	O
-	O
rearranged	O
pediatric	I:C0079731
B	I:C0079731
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
and	O
the	O
pathway	O
may	O
represent	O
a	O
highly	O
relevant	O
second	O
hit	O
of	O
Burkitt	B:C0006413
lymphoma	I:C0006413
pathogenesis	O
especially	O
in	O
children	O
and	O
adolescents	O
.	O

In	O
conclusion	O
ID3	O
-	O
TCF3	O
-	O
CCND3	O
pathway	O
genes	O
are	O
mutated	O
in	O
more	O
than	O
88	O
%	O
of	O
MYC	O
-	O
rearranged	O
pediatric	I:C0079731
B	I:C0079731
-	I:C0079731
cell	I:C0079731
Non-Hodgkin	I:C0079731
lymphoma	I:C0079731
and	O
the	O
pathway	O
may	O
represent	O
a	O
highly	O
relevant	O
second	O
hit	O
of	O
Burkitt	O
lymphoma	I:C0006413
pathogenesis	B:C0699748
especially	O
in	O
children	O
and	O
adolescents	O
.	O

